RankAlpha logo
Back to Rankings

GNTA

Genenta ScienceF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
GNTA vs peer average
39/100
GNTA vs. peer average (F vs. D)
Grade spread
C 2 · D 1 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ATYR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $50.99M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerATYRaTyr
GNTA
Genenta Science
ATYR
aTyr
Grade
F
F
Momentum
8
8
Value
42
58
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ATYR

GNTA / ATYR
Grade Position
Below peers
GNTA vs. peer average (F vs. D)
39/100
Momentum
8
ATYR
Value
42
ATYR
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GNTA
1
ATYR
aTyr Pharma Inc Common
F
20/100
Even
2
SCYX
SCYNEXIS Inc Common
F
20/100
Even
3
IMMP
Immutep Ltd ADR
F
20/100
Even
4
MGX
Metagenomi Therapeutics Inc Common
F
20/100
Even
5
RADX
Radiopharm Theranostics Ltd ADR
N/A
-
-
ATYR is the first peer returned for this comparison set.